Bottom line
What is IVFCX's expense ratio?
IVFCX's expense ratio is 1.95%, or about $195 a year on every $10,000 invested. That is more expensive than 97% of dividend & equity income funds we track (median 0.74%). It has no front-end sales load. Its expense ratio includes a 0.75% 12b-1 marketing fee.
Updated Jan 23, 2026
IVFCX fee table
| Net expense ratio | 1.95% |
|---|---|
| Gross expense ratio | 1.99% |
| Management fee | 0.74% |
| 12b-1 (distribution) fee | 0.75% |
| Other expenses | 0.5% |
| Fee waiver / reimbursement | -0.04% |
| Max front-end sales load | 0% |
| Max deferred sales charge | 1% |
| Redemption fee | 0% |
Source: Fund prospectus fee table, filed Jan 23, 2026
What IVFCX costs in dollars
The SEC requires every fund to show what a $10,000 investment would cost, assuming 5% annual returns and that you sell at the end of each period:
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| IVFCX | $302 | $624 | $1,073 | $2,126 |
Source: Fund prospectus expense example
The long-run cost of fees
On $100,000 growing at 6% a year for 20 years, a 1.95% expense ratio costs roughly $99,500 in lost growth, versus about $41,900 for the median dividend & equity income fund (0.74%).